RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
Clinical trial NCT05858814 · UNKNOWN
Trial details
- NCT number
- NCT05858814
- Sponsor
- Guangdong Ruishun Biotech Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-04
- Primary completion
- 2024-05-27
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.